Lund, Sweden – 11 December 2018 — Camurus (NASDAQ STO: CAMX) today announces that they are hosting a Capital Markets and R&D Day today in Stockholm.
Time: Tuesday 11 December, 1 pm – 4.30 pm CET
Venue: IVA Conference Center, Grev Turegatan 16, Stockholm
The event can be followed via a webcast at
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of cancer, endocrine diseases, pain and addiction, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com.
For more information
Fredrik Joabsson, VP Business Development
Tel. +46 (0)70 776 17 37
This information was submitted for publication at 12.45 pm CET on 11 December 2018.